Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Gene Therapy Market?

There has been a significant expansion in the gene therapy market size in the past few years. Projected growth indicates an increase from $12.52 billion in 2024 to $16.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 30.7%. The historical growth period witnessed an upsurge due to factors such as increased spending on pharmaceutical R&D, elevation in public-private partnerships, governmental funding, and escalating instances of spinal muscular atrophy.

We project substantial expansion within the gene therapy market in the years to come. Predictions estimate a growth to $31.48 billion by 2029, maintaining a compound annual growth rate (CAGR) of 17.8%. The progression during the prediction timeline is ascribed to the rising prevalence of cancer, an increasingly older population, more extensive spending on research and development in the drug sector, and heightened emphasis on gene therapy as market propellers. Key trends during this forecasted period encompass enhancing business procedures by garnering regulatory approvals, fortifying business operations through strategic collaborations and partnerships, broadening business competencies via strategic acquisitions, and bolstering operational capacities through business growth.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Gene Therapy Market?

The escalating prevalence of cancer and other targeted diseases is necessitating optimal therapies, thereby pushing the expansion of the gene therapy market. The global increase in cancer occurrences is expected to bolster the gene therapy market’s growth throughout the future projection period. For example, the American Cancer Society estimated in January 2022 that the U.S would witness about 1.9 million fresh cancer diagnoses and roughly 609,360 cancer-caused deaths, amounting to nearly 1,670 life losses every day. The four predominant cancer varieties around the world include lung, prostate, bowel, and female breast cancer, making up 43 percent of all newly diagnosed cancer cases. Consequently, the escalating rate of cancer globally is expected to spur the need for the gene therapy market in the upcoming years. Gene therapy, one of the highly effective oncological treatment methods, introduces new genes into a cancer cell or neighboring tissue to induce cell death or slow cancer’s proliferation.

Which Segments Define The Structure Of The Gene Therapy Market?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

What Strategic Shifts And Innovations Are Influencing The Gene Therapy Market?

Machine learning and artificial intelligence (AI) technologies are gradually becoming more prevalent in the gene therapy market. AI is essentially a machine version of human intellect, designed to reflect natural cognition. As a subset of AI, machine learning plays a key role. These technologies assist gene therapy market companies in thoroughly analysing pertinent data, shedding light on the interactions between tumors and immune cells, and providing improved accuracy in tissue sample evaluation, which often encounters disagreements between evaluators. For instance, in May 2023, Form Bio, an American bio software firm, introduced FORMsightAI. This innovative AI-based suite predicts and improves the production outcomes of cell and gene therapy constructs. It’s a comprehensive solution that merges state-of-the-art, adaptable AI models with Form Bio’s foundational platform, and a team of computational life sciences experts with experience in biology, bioinformatics, and data science. FORMsightAI is designed to resolve common problems cell and gene therapy developers encounter, such as construct truncations and manufacturing contaminations. These issues notably cause unacceptably low production yields, protracted market entry timescales, and safety concerns with therapies.

Who Are The Most Influential Companies In The Gene Therapy Market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Is Forecasted To Lead The Gene Therapy Market In The Coming Years?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model